• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ALINITY I ANTI-HCV REAGENT KIT; ASSAY, ENZYME LINKED IMMUNOSORBENT, HEPATITIS C VIRUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ALINITY I ANTI-HCV REAGENT KIT; ASSAY, ENZYME LINKED IMMUNOSORBENT, HEPATITIS C VIRUS Back to Search Results
Catalog Number 08P06-23
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/30/2022
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.Completed information for patient identification: sid (b)(6).This report is being filed on an international product, list number 08p06 that has a similar product distributed in the us, list number 08p05.All available patient information was included.Additional patient details are not available.
 
Event Description
The customer observed false negative alinity i anti-hcv results for a patient with chronic kidney disease on dialysis.The customer stated the patient tested before dialysis every time.The alinity i gave non-reactive results with 2 samples, but the backup machine gave reactive for both samples.Example result provided: (b)(6) 2022 sid (b)(6) initial result = 0.2 s/co, and the ortho clinical diagnostics backup instrument result = 3.0 s/co.The patient has a history of being anti-hcv positive for 2 years.No impact to patient management was reported.
 
Event Description
The customer observed false negative alinity i anti-hcv results for a patient with chronic kidney disease.The customer stated the patient tested before dialysis every time.The alinity i gave non-reactive results with 2 samples, but the backup machine gave reactive for both samples.Example result provided: (b)(6) 2022 sid (b)(6) initial result = 0.2 s/co, and the ortho clinical diagnostics backup instrument result = 3.0 s/co.The patient has a history of being anti-hcv positive for 2 years and is a dialysis patient.No impact to patient management was reported.
 
Manufacturer Narrative
The complaint investigation for falsely negative alinity i anti-hcv results included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review, and in house testing.Return testing was not completed as returns were not available.A review of tracking and trending did not identify any trends for the complaint issue.Labeling was reviewed and found to adequately address the issue.Device history record review on lot 40319be00 did not show any potential non-conformances, deviations, or non-conformances associated with the complaint issue.In-house testing of a retained reagent kit of the complaint lot was performed.All controls met specifications and no false non-reactive results were obtained, indicating that the sensitivity performance is not negatively impacted.Testing included two commercially available seroconversion panels.Lot 40319be00 detected the same bleeds as reactive with comparable s/co values for the seroconversion panels.Based on the investigation, no systemic issue or deficiency of the alinity i anti-hcv assay for lot number 40319be00 was identified.All available patient information was included.Additional patient details are not available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I ANTI-HCV REAGENT KIT
Type of Device
ASSAY, ENZYME LINKED IMMUNOSORBENT, HEPATITIS C VIRUS
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
EI   N39 E932
433331157
MDR Report Key16013605
MDR Text Key308528343
Report Number3002809144-2022-00448
Device Sequence Number1
Product Code MZO
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/13/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/20/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/21/2023
Device Catalogue Number08P06-23
Device Lot Number40319BE00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/12/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/10/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY I PROCESSING MODU, 03R65-01, AI02656; ALNTY I PROCESSING MODU, 03R65-01, AI02656
-
-